Azenta Inc (AZTA)vsIntuitive Surgical Inc (ISRG)
AZTA
Azenta Inc
$31.82
+5.61%
HEALTHCARE · Cap: $1.30B
ISRG
Intuitive Surgical Inc
$368.27
+1.88%
HEALTHCARE · Cap: $131.94B
Smart Verdict
WallStSmart Research — data-driven comparison
Intuitive Surgical Inc generates 1750% more annual revenue ($11.03B vs $596.48M). ISRG leads profitability with a 28.4% profit margin vs -29.1%. AZTA appears more attractively valued with a PEG of 0.53. ISRG earns a higher WallStSmart Score of 66/100 (B-).
AZTA
Buy53
out of 100
Grade: C-
ISRG
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+30.3%
Fair Value
$43.66
Current Price
$31.82
$11.84 discount
Margin of Safety
+80.5%
Fair Value
$1922.89
Current Price
$368.26
$1554.63 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 8778.0% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Strong operational efficiency at 33.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
18.5% revenue growth
Earnings expanding 26.5% YoY
Areas to Watch
1.0% revenue growth
Smaller company, higher risk/reward
ROE of -11.5% — below average capital efficiency
Currently unprofitable
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : AZTA
The strongest argument for AZTA centers on Price/Book, EPS Growth, Debt/Equity. PEG of 0.53 suggests the stock is reasonably priced for its growth.
Bull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.6%. Revenue growth of 18.5% demonstrates continued momentum.
Bear Case : AZTA
The primary concerns for AZTA are Revenue Growth, Market Cap, Return on Equity.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, P/E Ratio.
Key Dynamics to Monitor
AZTA profiles as a turnaround stock while ISRG is a growth play — different risk/reward profiles.
ISRG carries more volatility with a beta of 1.46 — expect wider price swings.
ISRG is growing revenue faster at 18.5% — sustainability is the question.
ISRG generates stronger free cash flow (948M), providing more financial flexibility.
Bottom Line
ISRG scores higher overall (66/100 vs 53/100), backed by strong 28.4% margins and 18.5% revenue growth. AZTA offers better value entry with a 30.3% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Azenta Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies within the biotechnology and pharmaceutical industries. The company excels in innovative automation and comprehensive biorepository services, facilitating faster drug discovery while ensuring adherence to stringent regulatory standards. With a forward-looking strategy that leverages advanced storage technologies and strategic partnerships, Azenta is uniquely positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to pioneering scientific research through sophisticated innovations underscores its potential appeal to institutional investors seeking exposure in the dynamic life sciences sector.
Visit Website →Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?